» Articles » PMID: 29069202

Association of Inflammation and Endothelial Dysfunction with Coronary Microvascular Resistance in Patients with Cardiac Syndrome X

Overview
Date 2017 Oct 26
PMID 29069202
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although a proportion of CSX patients have impaired brachial artery flow-mediated dilatation (FMD) in response to hyperemia, suggesting that endothelial dysfunction in these patients may be systemic and not just confined to the coronary circulation; the underlying mechanisms triggering endothelial dysfunction in these patients are still incompletely understood.

Objectives: To assess the association of the index of Microcirculatory Resistance (IMR) with endothelial dysfunction and inflammation in patients with CSX.

Methods: We studied 20 CSX patients and 20 age and gender-matched control subjects. Thermodilution-derived coronary flow reserve (CFR) and IMR were measured using a pressure-temperature sensor-tipped guidewire. Brachial artery FMD was measured using high-resolution, two-dimensional ultrasound images obtained with a Doppler ultrasound device (HDI-ATL 5000, USA) with a 5 MHz to 12 MHz linear-array transducer.

Results: Compared with in control subjects, CFR was significantly lower (2.42 ± 0.78 vs. 3.59 ± 0.79, p < 0.001); IMR was higher (32.2 ± 8.0 vs. 19.5 ± 5.5, p < 0.001); the concentration of hs-CRP and FMD was higher (4.75 ± 1.62 vs. 2.75 ± 1.50; 5.24 ± 2.41 vs. 8.57 ± 2.46, p < 0.001) in CSX patients. The Duke treadmill score (DTS) was correlated positively to CFR and FMD (0.489 and 0.661, p < 0.001), it was negative to IMR and hsCRP (-0.761 and -0.087, p < 0.001) in CSX patients.

Conclusions: The main finding in this study is that the DTS measured in patients with CSX was associated to hsCRP and FMD. Moreover, the independent effects of exercise tolerance can significantly impair FMD and hsCRP in CSX patients; especially it is particularly important to whom where FMD was associated negatively with IMR.

Citing Articles

The Role of Circulating Biomarkers in Patients with Coronary Microvascular Disease.

Quarta R, Martino G, Romano L, Lopes G, Greco F, Spaccarotella C Biomolecules. 2025; 15(2).

PMID: 40001480 PMC: 11853534. DOI: 10.3390/biom15020177.


Endothelial Senescence: From Macro- to Micro-Vasculature and Its Implications on Cardiovascular Health.

Wang P, Konja D, Singh S, Zhang B, Wang Y Int J Mol Sci. 2024; 25(4).

PMID: 38396653 PMC: 10889199. DOI: 10.3390/ijms25041978.


Circulating Biomarkers in Coronary Microvascular Dysfunction.

Chakrala T, Prakash R, Valdes C, Pepine C, Keeley E J Am Heart Assoc. 2023; 12(12):e029341.

PMID: 37301749 PMC: 10356037. DOI: 10.1161/JAHA.122.029341.


Traditional chinese medicine in coronary microvascular disease.

Yang Z, Lin S, Liu Y, Ren Q, Ge Z, Wang C Front Pharmacol. 2022; 13:929159.

PMID: 36003524 PMC: 9393228. DOI: 10.3389/fphar.2022.929159.


Myocardial Microvascular Physiology in Acute and Chronic Coronary Syndromes, Aortic Stenosis, and Heart Failure.

Larsen A, Fearon W, Anderson T, Pijls N J Interv Cardiol. 2022; 2022:9846391.

PMID: 35935124 PMC: 9297731. DOI: 10.1155/2022/9846391.


References
1.
Ong P, Sivanathan R, Borgulya G, Bizrah M, Iqbal Y, Andoh J . Obesity, inflammation and brachial artery flow-mediated dilatation: therapeutic targets in patients with microvascular angina (cardiac syndrome X). Cardiovasc Drugs Ther. 2012; 26(3):239-44. DOI: 10.1007/s10557-012-6382-4. View

2.
Tondi P, Santoliquido A, Di Giorgio A, Sestito A, Sgueglia G, Flore R . Endothelial dysfunction as assessed by flow-mediated dilation in patients with cardiac syndrome X: role of inflammation. Eur Rev Med Pharmacol Sci. 2011; 15(9):1074-7. View

3.
Lekakis J, Papamichael C, Anastasiou H, Alevizaki M, Desses N, Souvatzoglou A . Endothelial dysfunction of conduit arteries in insulin-dependent diabetes mellitus without microalbuminuria. Cardiovasc Res. 1997; 34(1):164-8. DOI: 10.1016/s0008-6363(97)00015-1. View

4.
Sestito A, Lanza G, Di Monaco A, Lamendola P, Careri G, Tarzia P . Relation between cardiovascular risk factors and coronary microvascular dysfunction in cardiac syndrome X. J Cardiovasc Med (Hagerstown). 2010; 12(5):322-7. DOI: 10.2459/JCM.0b013e3283406479. View

5.
Martinez G, Yong A, Fearon W, Ng M . The index of microcirculatory resistance in the physiologic assessment of the coronary microcirculation. Coron Artery Dis. 2015; 26 Suppl 1:e15-26. DOI: 10.1097/MCA.0000000000000213. View